Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Journal of Virology|September 16, 2016
Altered Glycosylation Patterns Increase Immunogenicity of a Subunit Hepatitis C Virus Vaccine, Inducing Neutralizing Antibodies Which Confer Protection in MiceDapeng Li, Markus von Schaewen, Xuesong Wang, et al.The Journal of Infectious Diseases|April 12, 2017
Immunization With a Subunit Hepatitis C Virus Vaccine Elicits Pan-Genotypic Neutralizing Antibodies and Intrahepatic T-Cell Responses in Nonhuman PrimatesDapeng Li, Xuesong Wang, Markus von Schaewen, et al.The Journal of Pediatrics|August 27, 2011
Performance of HIV-1 DNA or HIV-1 RNA tests for early diagnosis of perinatal HIV-1 infection during anti-retroviral prophylaxisMarianne Burgard, Stéphane Blanche, Carine Jasseron, et al.Nature Communications|July 27, 2017
Long-term hepatitis B infection in a scalable hepatic co-culture systemBenjamin Y Winer, Tiffany S Huang, Eitan Pludwinski, et al.Nature Communications|November 30, 2018
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responsesFlorian Douam, Carly G K Ziegler, Gabriela Hrebikova, et al.Journal of Virology|September 3, 2025
Assessment of hepatitis C virus permissiveness in iteratively genetically humanized miceMichael P Schwoerer, Sebastian Carver, Thomas R Cafiero, et al.Mbio|November 12, 2016
Expanding the Host Range of Hepatitis C Virus through Viral AdaptationMarkus von Schaewen, Marcus Dorner, Kathrin Hueging, et al.Plos Pathogens|September 8, 2025
Receptor transporter protein 4 (RTP4)-mediated repression of hepatitis C virus replication in mouse cellsMichael P Schwoerer, Sebastian Carver, Aaron E Lin, et al.Proceedings of the National Academy of Sciences of the United States of America|March 9, 2022
Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidateRuixue Wang, Saori Suzuki, Johnathan D Guest, et al.Science Translational Medicine|June 29, 2018
Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infectionBenjamin Y Winer, Elham Shirvani-Dastgerdi, Yaron Bram, et al.Pageof 3